Live Breaking News & Updates on Thalassemia thalassaemia
Stay updated with breaking news from Thalassemia thalassaemia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exa-cel earned its second FDA approval. The one-time therapy, which has a list price of $2.2 million in the United States, should be available for patients early this year.